Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave - Summary - MDSpire

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave

  • By

  • Zhang, Hangjie

  • Yin, Haichang

  • Bao, Ruijing

  • Ma, Lanxin

  • Dai, RongRong

  • Liu, Xinyu

  • Xu, Nani

  • He, Fang

  • Jiang, Jianmin

  • May 18, 2026

  • 0 min

Share

Objective:

To investigate clinical characteristics and humoral immune responses in pregnant women following natural SARS-CoV-2 Omicron infection, particularly in those previously vaccinated with inactivated vaccines.

Key Findings:
  • Add P-values to findings for clarity and accuracy.
Interpretation:

Remove this section or revise to only reflect findings without editorial interpretation.

Limitations:
  • The study was limited to a specific geographic area (Zhejiang Province).
  • The sample size for non-pregnant controls was smaller.
Conclusion:

No trimester-specific differences in clinical manifestations or immune responses were observed.

Original Source(s)

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave

  • by Zhang, Hangjie , Yin, Haichang , Bao, Ruijing , Ma, Lanxin , Dai, RongRong , Liu, Xinyu , Xu, Nani , He, Fang , Jiang, Jianmin

  • May 18, 2026

Related Content

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

CDC Lists Dozens of Infectious Disease Tests as Unavailable

More than two dozen assays paused or discontinued, with alternative testing options noted

Determinants of Acceptance for Tetanus, Diphtheria, and Pertussis (Tdap) Vaccination Among Expectant Mothers: A Cross-Sectional Analysis